Rigel Pharma (RIGL) Announces Settlement Agreement Resolving TAVALISSE Patent Litigation
Go back to Rigel Pharma (RIGL) Announces Settlement Agreement Resolving TAVALISSE Patent Litigation| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 43.47 +1.02 (2.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.45 | 52 Week High | $4.38 | |||
| Open | $42.31 | 52 Week Low | $1.88 | |||
| Day High | $43.50 | P/E | N/A | |||
| Day Low | $41.37 | EPS | $-1.12 | |||
| Volume | 107,011 | |||||
